The time to return to sport is shorter in the patient group treated with Autologous Conditioned Plasma (ACP) injections in combination with exercise therapy in comparison with the patient group treated with saline injections in combination with…
ID
Bron
Verkorte titel
Aandoening
Acute hamstring injury
Acute hamstringblessure
Autologous Conditioned Plasma (ACP)
Growth factors
Ondersteuning
University Medical Centre Utrecht
Sports Medical Centre of the Royal Dutch Football Association
KNVB Sportmedisch Centrum
Woudenbergseweg 56
3707 HX Zeist
telnr: 0343 499285/499150
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Time to return to full sports activity; either training or match play.
Achtergrond van het onderzoek
Muscle injuries account for up to 30% of injuries sustained in a sports event. In soccer, muscle injuries mostly occur in the calf and thigh. When injured, usually the RICE principle (rest, ice, compression, elevation) is practised, NSAID's are supplied and exercise therapy is given. However, there is little scientific evidence for the effectiveness of therapeutic interventions in muscle injuries.
In the last decade research has focussed on developing new treatment options for muscle injuries, including the use of growth factors. Research has shown that myoblasts can be proliferated by growth factors. Growth factors are present in autologous conditioned plasma (ACP). Injection of ACP has shown to increase regeneration in deliberately injured muscle in animals.
Only two studies examined the effect of ACP in human muscle injuries in relatively small heterogenous group of patients. Both studies showed that patients treated with ACP injections recovered faster from injury than patients in a non-randomized control group.
Objective:
In this study two treatment groups will be compared: ACP injection in combination with exercise therapy and placebo injection in combination with exercise therapy.
Study design:
Multi centre, double blind, randomized controlled trial comparing two treatment groups.
Study population:
80 patients with an acute hamstring lesion with MRI abnormalities.
Intervention:
Both the intervention group as the control group will perform exercise therapy. The intervention group is treated with ACP injection at maximal 5 days after the injury and the control group will receive placebo injection at the same time interval. A second injection is provided 5-7 days after the first injection. Injections are performed ultrasound guided in the lesion of the hamstring muscle.
Outcome measurements:
Primary: Time to return to full sports activity; either training or match play.
Secondary: Rate of recovery, hamstring force, recurrent hamstring lesions, pain score in rest, during sprinting and during isometric contraction assessed with the visual analogue scale (VAS), length of pain area during palpation, clinical hamstring- and sacroiliacal tests, hip- and knee range of motion, functional outcome, subjective patient satisfaction, prediction of patient and sports physician for time to return to sports, rediction of the patient of the used intervention (ACP or placebo),platelet count in whole blood and ACP, recovery hamstring lesion on MRI.
Follow-up will be performed after 1, 3, 4, 8, 10, 16, 26, 52 weeks and at return to sports.
Doel van het onderzoek
The time to return to sport is shorter in the patient group treated with Autologous Conditioned Plasma (ACP) injections in combination with exercise therapy in comparison with the patient group treated with saline injections in combination with exercise therapy.
Onderzoeksopzet
Follow-up will be performed after 1, 3, 4, 8, 10, 16, 26, 52 weeks and at return to sports.
Follow-up after 3, 4, 8, 10, 16 and 52 weeks will be performed by phone and will not consist a physical examination.
Onderzoeksproduct en/of interventie
In this double-blind randomised controlled trial two patient groups are compared:
1. Intervention group: ACP injections (3 ml in depots of 1 ml) in combination with exercise therapy;
2. Control group: Saline injections in combination with exercise therapy.
Two injections will be given with 5-7 days in between.
Publiek
Department of Sports Medicine <br>
PO BOX 411
J.L. Tol
Leidschendam 2260 AK
The Netherlands
+31 (0)70 3574235
h.tol@mchaaglanden.nl
Wetenschappelijk
Department of Sports Medicine <br>
PO BOX 411
J.L. Tol
Leidschendam 2260 AK
The Netherlands
+31 (0)70 3574235
h.tol@mchaaglanden.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. Clinical diagnosis of an acute hamstring injury, defined as:
A. Anamnestic acute injury;
B. Anamnestic pain in posterior thigh;
C. Localised pain during palpation of hamstring muscle;
D. Localised pain during passive straight leg raising;
E. Increasing pain during isometric contraction.
2. Isolated hamstring lesion on MRI (increased signal of injured muscle on T2 and/or STIR);
3. First injection will be performed maximal 5 days after injury;
4. Informed consent;
5. Age 18-50 years.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. Patient is not capable of doing an active exercise program;
2. Patient has received injection therapy for this injury before;
3. Patient does not have the intention to return to full sports activity;
4. Patient does not want to recieve one of the two therapies;
5. Cause of hamstring injury is an extrinsic trauma on posterior thigh;
6. Patient has chronic low back pain;
7. There are contraindications for MRI: Pacemaker, pregnancy, claustrofobia;
8. Patient has chronic hamstring complaints, defined as 13: recurrent pain or tenderness of hamstring muscle during at least 2 months;
9. There is a grade 3 lesion (total rupture) and/or avulsion on MRI.
Opzet
Deelname
Voornemen beschikbaar stellen Individuele Patiënten Data (IPD)
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL2643 |
NTR-old | NTR2771 |
CCMO | NL34660.098.10 |
ISRCTN | ISRCTN wordt niet meer aangevraagd. |
OMON | NL-OMON37939 |